Volume 100, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
Preview this article:
Zoom in

Malaria: How Are We Doing and How Can We Do Better?, Page 1 of 1

| /docserver/preview/fulltext/14761645/100/2/tpmd180997-1.gif

There is no abstract available for this article.
Use the preview function to the left.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 2018. World Malaria Report 2018. Geneva, Switzerland: WHO. [Google Scholar]
  2. Abeyasinghe RR, Galappaththy GN, Smith Gueye C, Kahn JG, Feachem RG, , 2012. Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One 7: e43162. [Google Scholar]
  3. Molineaux L, Gramiccia G, , 1980. The Garki Project. Geneva, Switzerland: World Health Organization. [Google Scholar]
  4. Protopopoff N, 2018. Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-two factorial design trial. Lancet 391: 15771588. [Google Scholar]
  5. Tiono AB, 2018. Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial. Lancet 392: 569580. [Google Scholar]
  6. Ranson H, , 2017. Current and future prospects for preventing malaria transmission via the use of insecticides. Cold Spring Harb Perspect Med 7: 111. [Google Scholar]
  7. James S, 2018. Pathway to deployment of gene drive mosquitoes as a potential biocontrol tool for elimination of malaria in sub-Saharan Africa: recommendations of a scientific working group. Am J Trop Med Hyg 98: 149. [Google Scholar]
  8. Fairhurst RM, Dondorp AM, , 2016. Artemisinin-resistant Plasmodium falciparum malaria. Microbiol Spectr 4: 116. [Google Scholar]
  9. West African Network for Clinical Trials of Antimalarial Drugs, 2018. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. Lancet 391: 13781390. [Google Scholar]
  10. Cisse B, 2016. Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: a stepped-wedge cluster-randomised trial. PLoS Med 13: e1002175. [Google Scholar]
  11. Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, Brooker SJ, Staedke SG, Kamya MR, , 2014. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis 58: 14041412. [Google Scholar]
  12. Desai M, 2015. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet 386: 25072519. [Google Scholar]
  13. Kakuru A, 2016. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med 374: 928939. [Google Scholar]
  14. Eisele TP, 2016. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in southern province Zambia: a cluster-randomized controlled trial. J Infect Dis 214: 18311839. [Google Scholar]
  15. Rosenthal PJ, , 2016. Azithromycin for malaria? Am J Trop Med Hyg 95: 24. [Google Scholar]
  16. Keenan JD, 2018. Azithromycin to reduce childhood mortality in sub-Saharan Africa. N Engl J Med 378: 15831592. [Google Scholar]
  17. Hemingway J, Shretta R, Wells TN, Bell D, Djimde AA, Achee N, Qi G, , 2016. Tools and strategies for malaria control and elimination: what do we need to achieve a grand convergence in malaria? PLoS Biol 14: e1002380. [Google Scholar]
  18. Hooft van Huijsduijnen R, Wells TN, , 2018. The antimalarial pipeline. Curr Opin Pharmacol 42: 16. [Google Scholar]
  19. Olotu A, Fegan G, Wambua J, Nyangweso G, Leach A, Lievens M, Kaslow DC, Njuguna P, Marsh K, Bejon P, , 2016. Seven-year efficacy of RTS,S/AS01 malaria vaccine among young African children. N Engl J Med 374: 25192529. [Google Scholar]
  20. Jongo SA, 2018. Safety, immunogenicity, and protective efficacy against controlled human malaria infection of Plasmodium falciparum sporozoite vaccine in Tanzanian adults. Am J Trop Med Hyg 99: 338349. [Google Scholar]
  21. Draper SJ, Sack BK, King CR, Nielsen CM, Rayner JC, Higgins MK, Long CA, Seder RA, , 2018. Malaria vaccines: recent advances and new horizons. Cell Host Microbe 24: 4356. [Google Scholar]
  22. Greenwood B, 2017. Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine. Malar J 16: 182. [Google Scholar]
  23. Warsame M, 2016. Pre-referral rectal artesunate treatment by community-based treatment providers in Ghana, Guinea-Bissau, Tanzania, and Uganda (study 18): a cluster-randomized trial. Clin Infect Dis 63: S312S321. [Google Scholar]
  24. Gething PW, 2016. Mapping Plasmodium falciparum mortality in Africa between 1990 and 2015. New Engl J Med 375: 24352445. [Google Scholar]
  • Received : 21 Dec 2018
  • Accepted : 21 Dec 2018
  • Published online : 08 Jan 2019

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error